© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Mark G. Kris, MD, FASCO provides insight on monitoring patients with NSCLC and discusses the developing role of ctDNA.
July 7th 2022
Mark G. Kris, MD, FASCO shares an overview of existing treatment options for patients with stage I-III non-small cell lung cancer.
Practical advice on monitoring options for patients with NSCLC treated with definitive radiation therapy or surgery.
Dr. Mark Kris shares insight on ctDNA and its use in detecting MRD in NSCLC.
A comprehensive review of data presented at ASCO 2022 on ctDNA and MRD detection in NSCLC.
A thoracic oncology expert provides perspective on ctDNA as a tool and its future as part of the NSCLC landscape.